CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 13.51: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.54%
Annual Rate
CNY 0.40Paid semi-annual
Payout Ratio
110.8%High
Payback Period
21.8 yr
Last Ex-Dividend
Apr 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.52BCNY671.99M · vs all stocks (USD)
Trailing P/E
43.46xRevenue (TTM)
659.54MCNY97.95M · vs all stocks (USD)
Profit Margin
15.28%Beta
0.1750xvs all stocks
52-Week Change
-23.80%vs all stocks
Forward Annual Dividend Yield
3.54%vs all stocks
Market Capitalization
4.52BCNY671.99M · vs all stocks (USD)
Enterprise Value
3.86BCNY573.53M · vs all stocks (USD)
Trailing P/E
43.46xPrice to Sales (TTM)
6.72xPrice to Book (MRQ)
2.79xEnterprise to Revenue
5.86xEnterprise to EBITDA
24.91xGross Margin
31.61%Profit Margin
15.28%Operating Margin
20.03%Return on Assets (TTM)
3.34%Return on Equity (TTM)
6.23%Revenue (TTM)
659.54MCNY97.95M · vs all stocks (USD)
Revenue per Share (TTM)
1.69CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-5.80%Gross Profit (TTM)
203.79MCNY30.27M · vs all stocks (USD)
EBITDA (TTM)
173.32MCNY25.74M · vs all stocks (USD)
Net Income (TTM)
100.78MCNY14.97M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-36.20%Operating Cash Flow (TTM)
60.92MCNY9.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-33.94MCNY-5.04M · vs all stocks (USD)
Forward Annual Dividend Rate
0.4000CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
3.54%vs all stocks
Trailing Annual Dividend Rate
0.4857CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
4.30%vs all stocks
Payout Ratio
110.83%Minority Interest (Equity)
-326.73KCNYFY2025 · Dec 31, 2025Revenue
672.38MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
437.63MCNYFY2025 · Dec 31, 2025Gross Profit
234.74MCNYFY2025 · Dec 31, 2025Operating Income
133.36MCNY19.81M · vs all stocks (USD)
Pre-tax Income
134.12MCNYFY2025 · Dec 31, 2025Income Tax Expense
14.06MCNYFY2025 · Dec 31, 2025Net Income
120.07MCNYFY2025 · Dec 31, 2025EBIT
134.34MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
199.06MCNYFY2025 · Dec 31, 2025Research & Development
46.18MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
21.65MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
211.97KCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
120.07MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.18MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
156.68MCNYFY2025 · Dec 31, 2025Free Cash Flow
55.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
169.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
120.07MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.26MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
66.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-31.67MCNYFY2025 · Dec 31, 2025Capital Expenditures
-101.33MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.01BCNYFY2025 · Dec 31, 2025Sale of Investments
2.99BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-115.28MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-112.02MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.80MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-113.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
392.08MSharesUpdated Aug 20, 2026Float Shares
99.62MSharesUpdated Aug 20, 2026% Held by Insiders
75.62%vs all stocks
% Held by Institutions
0.34%vs all stocks
Total Cash (MRQ)
666.23MCNY98.95M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.70CNYUpdated Aug 20, 2026Total Debt (MRQ)
3.94MCNY584.77K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0025xCurrent Ratio (MRQ)
6.35xBook Value per Share (MRQ)
4.05CNYUpdated Aug 20, 2026Total Assets
1.78BCNY264.29M · vs all stocks (USD)
Total Current Assets
1.07BCNYFY2025 · Dec 31, 2025Total Liabilities
228.49MCNYFY2025 · Dec 31, 2025Total Non-current Assets
712.82MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
58.14MCNYFY2025 · Dec 31, 2025Total Current Liabilities
170.35MCNYFY2025 · Dec 31, 2025Cash
169.00MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
169.00MCNYFY2025 · Dec 31, 2025Other Short-term Investments
549.55MCNYFY2025 · Dec 31, 2025Accounts Receivable
130.97MCNYFY2025 · Dec 31, 2025Inventory
72.37MCNYFY2025 · Dec 31, 2025Accounts Payable
97.68MCNYFY2025 · Dec 31, 2025Short-term Debt
2.81MCNYFY2025 · Dec 31, 2025Other Current Liabilities
426.11KCNYFY2025 · Dec 31, 2025Long-term Debt
2.89MCNYFY2025 · Dec 31, 2025Common Stock (Book)
392.08MCNYFY2025 · Dec 31, 2025Retained Earnings
507.92MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.55BCNY230.36M · vs all stocks (USD)
52-Week Low
8.45CNYUpdated Aug 20, 202652-Week High
14.89CNYUpdated Aug 20, 202652-Week Change
-23.80%vs all stocks
Beta
0.1750xvs all stocks
50-Day MA
9.96CNYUpdated Aug 20, 2026200-Day MA
11.45CNYUpdated Aug 20, 2026Avg 10-Day Volume
10.96MSharesUpdated Aug 20, 2026Avg 30-Day Volume
10.54MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2600CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.51: safe zoneNotable
Altman Z-Score: 13.51
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Tianjin Lisheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gyre Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Yatai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Supriya Lifescience Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Contec Medical Systems Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qurient Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Qianjiang Yongan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai ShenQi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities